{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:30:14Z","timestamp":1795095014216,"version":"4.10.2"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Vasoplegia is common after cardiac surgery, is associated with hyperreninemia, and can lead to acute kidney stress. We aimed to conduct a pilot study to test the hypothesis that, in vasoplegic cardiac surgery patients, angiotensin-II (AT-II) may not increase kidney stress (measured by [TIMP-2]*[IGFBP7]).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We randomly assigned patients with vasoplegia (cardiac index [CI] &gt; 2.1l\/min, postoperative hypotension requiring vasopressors) and \u0394-renin (4-hour postoperative\u2013preoperative value) \u22653.7 \u00b5U\/mL, to AT-II or placebo targeting a mean arterial pressure \u226565 mm Hg for 12 hours. The primary end point was the incidence of kidney stress defined as the difference between baseline and 12 hours [TIMP-2]*[IGFBP7] levels. Secondary end points included serious adverse events (SAEs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      We randomized 64 patients. With 1 being excluded, 31 patients received AT-II, and 32 received placebo. No significant difference was observed between AT-II and placebo groups for kidney stress (\u0394-[TIMP-2]*[IGFBP7] 0.06 [ng\/mL]\n                      <jats:sup>2<\/jats:sup>\n                      \/1000 [Q1\u2013Q3, \u22120.24 to 0.28] vs \u22120.08 [ng\/mL]\n                      <jats:sup>2<\/jats:sup>\n                      \/1000 [Q1\u2013Q3, \u22120.35 to 0.14];\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .19; Hodges-Lehmann estimation of the location shift of 0.12 [ng\/mL]\n                      <jats:sup>2<\/jats:sup>\n                      \/1000 [95% confidence interval, CI, \u22120.1 to 0.36]). AT-II patients received less fluid during treatment than placebo patients (2946 vs 3341 mL,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .03), and required lower doses of norepinephrine equivalent (0.19 mg vs 4.18mg,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; .001). SAEs were reported in 38.7% of patients in the AT-II group and in 46.9% of patients in the placebo group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The infusion of AT-II for 12 hours appears feasible and did not lead to an increase in kidney stress in a high-risk cohort of cardiac surgery patients. These findings support the cautious continued investigation of AT-II as a vasopressor in hyperreninemic cardiac surgery patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000006839","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T13:00:41Z","timestamp":1706619641000},"page":"165-173","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["A Pilot Study of Renin-Guided Angiotensin-II Infusion to Reduce Kidney Stress After Cardiac Surgery"],"prefix":"10.1213","volume":"139","author":[{"given":"Mahan","family":"Sadjadi","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilo","family":"von Groote","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Weiss","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Strau\u00df","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Wempe","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Albert","sequence":"additional","affiliation":[{"name":"Institute of Biostatistics and Clinical Research, University of M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Langenk\u00e4mper","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[{"name":"Department of Intensive Care and Anesthesia, IRCCS San Raffaele Scientific Institute, Milan, Italy"},{"name":"Department of Anesthesia and Intensive Care, School of Medicine, Vita-Salute San Raffaele University, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[{"name":"Department of Critical Care, The University of Melbourne, Melbourne, Australia"},{"name":"Department of Intensive Care, Royal Melbourne Hospital, Parkville, Victoria, Australia"},{"name":"Department of Intensive Care, Austin Health, Heidelberg, Australia"},{"name":"Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K.","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Section on Critical Care Medicine, School of Medicine, Wake Forest University, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, North Carolina"},{"name":"Outcomes Research Consortium, Cleveland, Ohio"},{"name":"Perioperative Outcomes and Informatics Collaborative (POIC), Winston-Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Coulson","sequence":"additional","affiliation":[{"name":"Department of Critical Care, The University of Melbourne, Melbourne, Australia"},{"name":"Department of Anesthesiology and Perioperative Medicine, The Alfred Hospital, Melbourne, Victoria, Australia; Department of Critical Care, University of Melbourne, Melbourne, Victoria, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Meersch","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Intensive Care and Pain Medicine, University Hospital M\u00fcnster, M\u00fcnster, Germany"},{"name":"Outcomes Research Consortium, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"R1-20250502","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semtcvs.2010.09.007","article-title":"Vasoplegia during cardiac surgery: current concepts and management.","volume":"22","author":"Fischer","year":"2010","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"R2-20250502","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1097\/01.CCM.0000186749.34028.40","article-title":"Arginine vasopressin in 316 patients with advanced vasodilatory shock.","volume":"33","author":"Luckner","year":"2005","journal-title":"Crit Care Med"},{"key":"R3-20250502","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/j.1365-2044.2006.04779.x","article-title":"Association between vasopressor dependence and early outcome in patients after cardiac surgery.","volume":"61","author":"Weis","year":"2006","journal-title":"Anaesthesia"},{"key":"R4-20250502","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.jvca.2018.08.003","article-title":"Acute kidney injury after cardiac surgery: a narrative review of the literature.","volume":"33","author":"Chew","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R5-20250502","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1161\/CIRCULATIONAHA.108.800011","article-title":"Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery.","volume":"119","author":"Hobson","year":"2009","journal-title":"Circulation"},{"key":"R6-20250502","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41581-018-0052-0","article-title":"Global epidemiology and outcomes of acute kidney injury.","volume":"14","author":"Hoste","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"R7-20250502","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrneph.2017.119","article-title":"Cardiac surgery-associated acute kidney injury: risk factors, pathophysiology and treatment.","volume":"13","author":"Wang","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"R8-20250502","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for postcardiopulmonary bypass vasoplegic shock.","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R9-20250502","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.jvca.2020.08.001","article-title":"Treatment with angiotensin II is associated with rapid blood pressure response and vasopressor sparing in patients with vasoplegia after cardiac surgery: a post-hoc analysis of angiotensin II for the treatment of high-output shock (ATHOS-3) study.","volume":"35","author":"Klijian","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R10-20250502","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10557-020-07098-3","article-title":"The use of angiotensin ii for the treatment of post-cardiopulmonary bypass vasoplegia.","volume":"36","author":"Papazisi","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"key":"R11-20250502","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery.","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"R12-20250502","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock.","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"R13-20250502","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1164\/rccm.201911-2172OC","article-title":"Renin and survival in patients given angiotensin ii for catecholamine-resistant vasodilatory shock.","volume":"202","author":"Bellomo","year":"2020","journal-title":"A Clinical Trial. Am J Resp Crit Care Med"},{"key":"R14-20250502","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II.","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R15-20250502","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/01.HYP.21.5.704","article-title":"Effects of losartan on blood pressure, plasma renin activity, and angiotensin II in volunteers.","volume":"21","author":"Goldberg","year":"1993","journal-title":"Hypertension"},{"key":"R16-20250502","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1164\/rccm.202005-2050OC","article-title":"Kinetic changes of plasma renin concentrations predict acute kidney injury in cardiac surgery patients.","volume":"203","author":"Kullmar","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"R17-20250502","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery.","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"R18-20250502","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.36.5.839","article-title":"Angiotensin II infused intrarenally causes preglomerular vascular changes and hypertension.","volume":"36","author":"Stevenson","year":"2000","journal-title":"Hypertension"},{"key":"R19-20250502","doi-asserted-by":"crossref","first-page":"R142","DOI":"10.1186\/cc9207","article-title":"Early administration of norepinephrine increases cardiac preload and cardiac output in septic patients with life-threatening hypotension.","volume":"14","author":"Hamzaoui","year":"2010","journal-title":"Crit Care"},{"key":"R20-20250502","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/cc12503","article-title":"Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury.","volume":"17","author":"Kashani","year":"2013","journal-title":"Crit Care"},{"key":"R21-20250502","doi-asserted-by":"crossref","first-page":"e93460","DOI":"10.1371\/journal.pone.0093460","article-title":"Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery.","volume":"9","author":"Meersch","year":"2014","journal-title":"PLoS One"},{"key":"R22-20250502","doi-asserted-by":"crossref","first-page":"e2019209","DOI":"10.1001\/jamanetworkopen.2020.19209","article-title":"Recommendations on acute kidney injury biomarkers from the acute disease quality initiative consensus conference: a consensus statement.","volume":"3","author":"Ostermann","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R23-20250502","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","article-title":"Biomarker-guided Intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study.","volume":"267","author":"Gocze","year":"2018","journal-title":"Ann Surg"},{"key":"R24-20250502","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","article-title":"Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial.","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med"},{"key":"R25-20250502","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13054-023-04322-y","article-title":"An updated \u201cnorepinephrine equivalent\u201d score in intensive care as a marker of shock severity.","volume":"27","author":"Kotani","year":"2023","journal-title":"Crit Care"},{"key":"R26-20250502","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin II as primary vasopressor in critically ill adults with vasodilatory hypotension: the Aramis study.","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"R27-20250502","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2023.06.056","article-title":"Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial.","volume":"131","author":"Coulson","year":"2023","journal-title":"Br J Anaesth"},{"key":"R28-20250502","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13054-023-04446-1","article-title":"Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.","volume":"27","author":"Wieruszewski","year":"2023","journal-title":"Crit Care"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006839","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:32:22Z","timestamp":1786113142000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000006839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000006839","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,30]]}}}